Progranulin in frontotemporal lobar degeneration and neuroinflammation

Overview of attention for article published in Journal of Neuroinflammation, February 2007

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet
blogs: 2 blogs

twitter: 1 X user

Citations

dimensions_citation: 201 Dimensions

Readers on

mendeley: 197 Mendeley
citeulike: 2 CiteULike

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 3 news stories from 1 outlets.

Prevail on go with study of gene therapy for type of dementia; shares up 7%

Seeking Alpha, 02 Mar 2020

The FDA has signed off on Prevail Therapeutics' (PRVL +7.4%) IND for a Phase 1/2 clinical trial, PROCLAIM, evaluating gene…

Alector's AL101 Fast Track'd for FTD; shares up 7%

Seeking Alpha, 05 Feb 2020

The FDA designates Alector's (ALEC +6.8%) AL101 for Fast Track review for the treatment of patients with progranulin gene…

Alector's AL001 Fast Track'd in U.S. for type of dementia

Seeking Alpha, 05 Dec 2019

The FDA designates Alector's (NASDAQ: ALEC ) lead candidate AL001 for Fast Track review for the treatment of frontotemporal…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.